Earnings Outlook For Karyopharm Therapeutics
Karyopharm Therapeutics (NASDAQ:KPTI) is set to give its latest quarterly earnings report on Monday, 2025-08-11. Here's what investors need to know before the announcement.
Analysts estimate that Karyopharm Therapeutics will report an earnings per share (EPS) of $-3.86.
The announcement from Karyopharm Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Performance in Previous Earnings
In the previous earnings release, the company beat EPS by $0.32, leading to a 20.0% drop in the share price the following trading session.
Here's a look at Karyopharm Therapeutics's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -3.09 | -4.05 | -3.9 | -4.5 |
| EPS Actual | -2.77 | -3.60 | -3.9 | -3 |
| Price Change % | -20.0% | 2.0% | 5.0% | -3.0% |
Stock Performance
Shares of Karyopharm Therapeutics were trading at $3.97 as of August 07. Over the last 52-week period, shares are down 67.44%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
